Could AI Replace Colonoscopy? A New Stool Test Detects 90% of Colorectal Cancers
ScienceDaily reports on a stool test that detects 90% of colorectal cancers, adding fuel to the debate over noninvasive screening. The result could reshape screening behavior, but only if sensitivity, specificity, and follow-up pathways hold up outside the study setting.
A noninvasive stool test with a 90% colorectal cancer detection rate is the kind of result that can quickly capture public imagination. The headline almost writes itself: if you can detect cancer without colonoscopy, a major barrier to screening may fall.
But screening is a system, not a single test. A high detection rate is only part of the story; specificity, false-positive burden, detection of precancerous lesions, and the ability to channel positive tests into timely colonoscopy all determine whether the new assay improves outcomes.
That is where AI increasingly enters the picture. The commercial and scientific push is toward multi-cancer, blood-based, or stool-based tests that use computation to interpret faint signals at scale. The promise is not merely convenience, but broader uptake among patients who avoid invasive procedures.
Still, colonoscopy remains the gold standard because it can diagnose and treat in the same encounter. A stool test may become an important first-line screen, but claims that it can replace colonoscopy should be treated as provisional until long-term outcome data show that earlier detection actually saves more lives.